Brain metastases from colorectal carcinoma: prognostic factors and outcome.
Brain metastases from colorectal carcinoma (CRC) are rare. The objectives of this study are to assess the natural history, outcome, and possible prognostic factors in CRC patients with brain metastases. Between 1995 and 2008, 8,732 patients with CRC were treated at Yonsei University Health System. Brain metastases were found in 1.4% of these patients. Retrospective review and statistical analysis of these 126 patients were performed. Median time from diagnosis of metastatic CRC (mCRC) to brain metastases was 9.0 months (range 0-85 months), and 14 patients (11.1%) had brain involvement as their initial presentation. Among the 126 patients, 91.3% had other systemic metastases; the most common extracranial metastatic site was lung (72.2%). Median follow-up duration was 6.1 months (range 0.1-90.3 months), and median survival after diagnosis of brain metastases was 5.4 months [95% confidence interval (CI) 3.9-6.9 months]. Median survival time after diagnosis of brain metastases was 1.5 months for patients who received only steroids (15.9%), 4.0 months for those who received whole-brain radiation therapy (37.5%), 9.5 months for those who received gamma-knife surgery (GKS) (32.5%), and 11.5 months for those who underwent surgery (20%) (P < 0.001). On multivariate analysis, recursive partitioning analysis (RPA) class and amount of chemotherapy before brain metastasis were independent prognostic factors for survival. Overall prognosis of patients with brain metastases from CRC is poor. Nevertheless, patients with low RPA class, or those with previous less chemotherapy showed good prognosis, indicating that proper treatment may result in improved survival time.
Jung
Minkyu
M
Yonsei University Health System, Seoul, Korea.
Ahn
Joong Bae
JB
Chang
Jong Hee
JH
Suh
Chang Ok
CO
Hong
Soojung
S
Roh
Jae Kyung
JK
Shin
Sang Joon
SJ
Rha
Sun Young
SY
D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D015179:Colorectal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D016371:Cranial Irradiation; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016634:Radiosurgery; D012189:Retrospective Studies; D016896:Treatment Outcome
Ann Surg. 1966 Jun;163(6):829-37
5933797
J Clin Oncol. 2004 Apr 1;22(7):1209-14
15051767
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
19474385
Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1252-7
17442021
Cancer. 1996 Aug 15;78(4):711-6
8756361
Cancer. 1999 Apr 15;85(8):1677-85
10223560
Curr Opin Neurol. 2001 Dec;14(6):717-23
11723379
Med Pediatr Oncol. 1980;8(3):305-8
7464689
Curr Treat Options Oncol. 2001 Dec;2(6):537-47
12057099
J Clin Oncol. 2004 Jul 15;22(14):2865-72
15254054
J Clin Oncol. 2003 Jul 1;21(13):2529-36
12829672
Clin Colorectal Cancer. 2005 Jul;5(2):108-13
16098251
J Neurooncol. 2009 Feb;91(3):307-13
18949445
Neurol Clin. 2003 Feb;21(1):1-23, vii
12690643
J Clin Neurosci. 2008 Sep;15(9):998-1004
18617411
Oncology. 2009;76(5):369-74
19321946
J Cancer Res Clin Oncol. 2009 Mar;135(3):451-7
18779977
J Neurooncol. 1983;1(3):203-9
6678969
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51
9128946
Cancer. 2002 May 15;94(10):2698-705
12173339
Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1169-76
12654423
Ann Surg Oncol. 1996 Sep;3(5):453-63
8876887
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1001-6
10863071
Cancer. 2008 Jul 1;113(1):158-65
18459179